NewG Lab rises 9.64% amid COVID-19 (diagnostics/treatment/vaccine development) theme uptrend

On the 4th, the COVID-19 (diagnosis/treatment/vaccine development, etc.) theme rose by 3.16% compared to the previous day, showing strength, while Newgelab, a related stock drawing attention, surged by 9.64% compared to the previous day. Newgelab is known as a CCTV camera manufacturer.

[Graph] Major stock price changes in the COVID-19 (diagnosis/treatment/vaccine development, etc.) theme



According to provisional data compiled at 14:02, foreigners are net selling -2,800 shares of Newgelab.

[Table] Net trading volume of foreigners and institutions (unit: 10,000 shares)



According to the analysis by Thinkpool Robo Algorithm RASSI, Newgelab’s quant financial score is 19.52 points, which is higher in growth and stability scores than the average of other stocks related to the COVID-19 (diagnosis/treatment/vaccine development, etc.) theme, ranking 19th within the theme. This indicates that compared to other stocks in the theme, Newgelab’s sales and net profit growth rates are relatively fast, and its ability to respond to changes in domestic and international economic environments is also good.

[Table] Top stocks by financial score within the theme


※ The quant financial score is the result of analysis by the Robo Algorithm based on each company’s sales growth rate, equity growth rate, debt ratio, current ratio, ROA, ROE, etc.

※ This article was generated in real time by an article automatic generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.

This content was produced with the assistance of AI translation services.